{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:59Z","timestamp":1792791539898,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671263"],"award-info":[{"award-number":["81671263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023AH010072"],"award-info":[{"award-number":["2023AH010072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111195","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:51:56Z","timestamp":1790434316000},"page":"111195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proteasome-dependent degradation of DAPK1 by wogonoside blocks PARthanatos and protects against ischemic stroke"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8933-4102","authenticated-orcid":false,"given":"Chun-Ze","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Liu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Xiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-4114","authenticated-orcid":false,"given":"Xiao-Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.neuropharm.2026.111195_bib1","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"Andrabi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111195_bib2","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111195_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111195_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"20","author":"Collaborators","year":"2021","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111195_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111195_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41419-023-06284-z","article-title":"NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis","volume":"14","author":"Dondelinger","year":"2023","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111195_bib7","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: mitochondrial\u2010linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111195_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/10915810600961531","article-title":"Nonclinical vehicle use in studies by multiple routes in multiple species","volume":"25","author":"Gad","year":"2006","journal-title":"Int. J. Toxicol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111195_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly (ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111195_bib10","article-title":"Bifendate inhibits cell PARthanatos by activating the MEK\/ERK pathway","volume":"45","author":"Hu","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111195_bib11","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.3390\/ijms23137292","article-title":"Molecular mechanisms of parthanatos and its role in diverse diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111195_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111195_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111195_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"6121","key":"10.1016\/j.neuropharm.2026.111195_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/cas systems","volume":"339","author":"Le Cong","year":"2013","journal-title":"Science (Wash. D C)"},{"key":"10.1016\/j.neuropharm.2026.111195_bib16","article-title":"Oxidative cell death in the central nervous system: mechanisms and therapeutic strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111195_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41593-026-02201-7","article-title":"Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos","volume":"29","author":"Mace","year":"2026","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111195_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2011.01398.x","article-title":"Preclinical stroke research\u2013advantages and disadvantages of the most common rodent models of focal ischaemia","volume":"164","author":"Macrae","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111195_bib19","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1021\/jm8001263","article-title":"4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2 H-phthalazin-1-one: a novel bioavailable inhibitor of poly (ADP-ribose) polymerase-1","volume":"51","author":"Menear","year":"2008","journal-title":"J. Med. Chem."},{"issue":"6141","key":"10.1016\/j.neuropharm.2026.111195_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111195_bib21","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111195_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8377362","article-title":"Baicalein, baicalin, and wogonin: protective effects against ischemia-induced neurodegeneration in the brain and retina","volume":"2021","author":"Pan","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.111195_bib23","doi-asserted-by":"crossref","first-page":"19631","DOI":"10.1021\/jacs.5c22859","article-title":"Covalent inhibitors of monoacylglycerol lipase induce conformational changes and proteasomal degradation","volume":"148","author":"Pham","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111195_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","article-title":"Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma","volume":"21","author":"Qin","year":"2023","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111195_bib25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111195_bib26","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"8098","key":"10.1016\/j.neuropharm.2026.111195_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41586-025-09763-9","article-title":"Inhibitors supercharge kinase turnover through native proteolytic circuits","volume":"649","author":"Scholes","year":"2026","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111195_bib28","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111195_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2026.111195_bib30","series-title":"Neuronal Cell Death: Methods and Protocols","first-page":"197","article-title":"In vitro oxygen-glucose deprivation to study ischemic cell death","author":"Tasca","year":"2014"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111195_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.neuropharm.2026.111195_bib32","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.111195_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1843673","article-title":"Bruceine E, a natural quassinoid from Brucea javanica, inhibits PARthanatos via targeting PARP1 in ischemic stroke","volume":"17","author":"Wei","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111195_bib34","series-title":"SARM1 is an Essential Component of Neuronal Parthanatos","author":"Wu","year":"2025"},{"issue":"5579","key":"10.1016\/j.neuropharm.2026.111195_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1072221","article-title":"Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor","volume":"297","author":"Yu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111195_bib37","article-title":"Polyphenolic metabolites in Scutellaria baicalensis as potential candidate agents for the treatment of ischemic stroke","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111195_bib36","article-title":"Death-associated protein kinase 1: a double-edged sword in health and disease","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111195_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery","volume":"107","author":"Zou","year":"2022","journal-title":"Int. J. Surg."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:12Z","timestamp":1792788792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S0028390826003709"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111195","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteasome-dependent degradation of DAPK1 by wogonoside blocks PARthanatos and protects against ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111195"}}